These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35400867)

  • 1. Potential of nuclear magnetic resonance metabolomics in the study of prostate cancer.
    Reddy RR; Jagannathan NR
    Indian J Urol; 2022; 38(2):99-109. PubMed ID: 35400867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.
    Zheng H; Dong B; Ning J; Shao X; Zhao L; Jiang Q; Ji H; Cai A; Xue W; Gao H
    Clin Chim Acta; 2020 Feb; 501():241-251. PubMed ID: 31758937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMR-based metabolomics studies of human prostate cancer tissue.
    Lima AR; Pinto J; Bastos ML; Carvalho M; Guedes de Pinho P
    Metabolomics; 2018 Jun; 14(7):88. PubMed ID: 30830350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of prostate cancer by magnetic resonance spectroscopy (MRS).
    Sharma U; Jagannathan NR
    Biophys Rev; 2020 Oct; 12(5):1163-1173. PubMed ID: 32918707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinct Metabolic Signatures of Hormone-Sensitive and Castration-Resistant Prostate Cancer Revealed by a
    Zheng H; Zhu Y; Shao X; Cai A; Dong B; Xue W; Gao H
    J Proteome Res; 2020 Sep; 19(9):3741-3749. PubMed ID: 32702989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of characteristic metabolic panels for different stages of prostate cancer by
    Zhang X; Xia B; Zheng H; Ning J; Zhu Y; Shao X; Liu B; Dong B; Gao H
    J Transl Med; 2022 Jun; 20(1):275. PubMed ID: 35715864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NMR spectroscopy of filtered serum of prostate cancer: A new frontier in metabolomics.
    Kumar D; Gupta A; Mandhani A; Sankhwar SN
    Prostate; 2016 Sep; 76(12):1106-19. PubMed ID: 27197810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New findings on urinary prostate cancer metabolome through combined GC-MS and
    Lima AR; Pinto J; Barros-Silva D; Jerónimo C; Henrique R; Bastos ML; Carvalho M; Guedes Pinho P
    Metabolomics; 2020 Jun; 16(6):70. PubMed ID: 32495062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies.
    Lima AR; Bastos Mde L; Carvalho M; Guedes de Pinho P
    Transl Oncol; 2016 Aug; 9(4):357-70. PubMed ID: 27567960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Bruzzone C; Loizaga-Iriarte A; Sánchez-Mosquera P; Gil-Redondo R; Astobiza I; Diercks T; Cortazar AR; Ugalde-Olano A; Schäfer H; Blanco FJ; Unda M; Cannet C; Spraul M; Mato JM; Embade N; Carracedo A; Millet O
    J Proteome Res; 2020 Jun; 19(6):2419-2428. PubMed ID: 32380831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear magnetic resonance spectroscopy as a new approach for improvement of early diagnosis and risk stratification of prostate cancer.
    Yang B; Liao GQ; Wen XF; Chen WH; Cheng S; Stolzenburg JU; Ganzer R; Neuhaus J
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):921-933. PubMed ID: 29119730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NMR-Based Prostate Cancer Metabolomics.
    Euceda LR; Andersen MK; Tessem MB; Moestue SA; Grinde MT; Bathen TF
    Methods Mol Biol; 2018; 1786():237-257. PubMed ID: 29786797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of in vitro nuclear magnetic resonance of biofluids and tissues in clinical research.
    Dubey R; Sinha N; Jagannathan NR
    NMR Biomed; 2023 Apr; 36(4):e4686. PubMed ID: 34970810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant components of the Thoroughbred metabolome characterised by (1) H-nuclear magnetic resonance spectroscopy: A metabolite atlas of common biofluids.
    Escalona EE; Leng J; Dona AC; Merrifield CA; Holmes E; Proudman CJ; Swann JR
    Equine Vet J; 2015 Nov; 47(6):721-30. PubMed ID: 25130591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution NMR spectroscopy of human body fluids and tissues in relation to prostate cancer.
    Kumar V; Dwivedi DK; Jagannathan NR
    NMR Biomed; 2014 Jan; 27(1):80-9. PubMed ID: 23828638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics of cancer.
    Serkova NJ; Glunde K
    Methods Mol Biol; 2009; 520():273-95. PubMed ID: 19381962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Metabolomics Using NMR.
    Sharma U; Jagannathan NR
    Methods Mol Biol; 2019; 2037():195-213. PubMed ID: 31463847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of sampling procedures and day-to-day variations in metabolomics studies of biofluids.
    Giskeødegård GF; Andreassen T; Bertilsson H; Tessem MB; Bathen TF
    Anal Chim Acta; 2019 Nov; 1081():93-102. PubMed ID: 31446969
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.